Literature DB >> 2888525

Beta-blocker therapy and the risk of anaphylaxis.

J H Toogood.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 2888525      PMCID： PMC1267261     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Practolol and isoprenaline in status asthmaticus.

Authors:  J C Howard; P Cochrane; M Conway
Journal:  Lancet       Date:  1972-07-01       Impact factor: 79.321

2.  Antagonism by beta-adrenoceptor blocking agents of the antianaphylactic effect of isoprenaline.

Authors:  E S Assem; H O Schild
Journal:  Br J Pharmacol       Date:  1971-08       Impact factor: 8.739

3.  Beta-adrenergic blockers in the hypertensive asthmatic patient?

Authors:  J D Wallin
Journal:  Chest       Date:  1985-12       Impact factor: 9.410

4.  Characterization of the receptor mediating the antianaphylactic effects of beta-adrenoceptor agonists in human lung tissue in vitro.

Authors:  P R Butchers; I F Skidmore; C J Vardey; A Wheeldon
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

5.  Respiratory and cardiac effects of metoprolol and bevantolol in patients with asthma.

Authors:  P G Wilcox; D Ahmad; A C Darke; J Parsons; S G Carruthers
Journal:  Clin Pharmacol Ther       Date:  1986-01       Impact factor: 6.875
  5 in total
  1 in total

Review 1.  Outpatient Emergencies: Anaphylaxis.

Authors:  Scott P Commins
Journal:  Med Clin North Am       Date:  2017-03-02       Impact factor: 5.456
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.